An International Multi-Centre Study Of Anastrozole Versus Placebo In Postmenopausal Women At Increased Risk Of Breast Cancer.

Trial Profile

An International Multi-Centre Study Of Anastrozole Versus Placebo In Postmenopausal Women At Increased Risk Of Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2017

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Breast cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms IBIS-II; IBIS-II-Prevention
  • Most Recent Events

    • 23 Nov 2015 Results published in the Journal of Clinical Oncology
    • 05 Apr 2014 Results for the effect on bone turnover markers presented at the 2014 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    • 12 Dec 2013 Results published in the Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top